DocGo chairman staying on should boost confidence, says Canaccord

Canaccord analyst Richard Close says the news of Stan Vashovsky staying on as DocGo chairman is a net positive "as it should bolster investor confidence." The share pullback over the last several months is not indicative of the "significant growth opportunities that the company has alluded to, albeit specific details have not been provided," Close tells investors in a research note. The analyst continues to believe that DocGo is an attractive investment based on its "strong growth outlook and profitable profile." He reiterates a Buy rating on the shares with an $11 price target.